News

Hantavirus 5-Point Screen Tool Identifies Patients With Deadly Infection

Researchers at Tséhootsooí Medical Center and Emory University find that screening tool accurately differentiates Hantavirus and COVID-19


 

In May 2016, Tarrah Oliver had been working as a bench tech in hematology at Tséhootsooí Medical Center (TMC) for 4 years when the hospital launched a 5-point screen for detecting hantavirus cardiopulmonary syndrome (HCPS), a potentially fatal disease that disproportionately affects Native Americans.

Developed at the University of New Mexico, the 5-point screen was particularly useful for facilities like TMC , a 56-bed hospital in Arizona serving Navajo Nation patients. Although the Navajo make up only 1.7% of the population, they account for 18% of all reported HCPS cases in the US.

But Oliver, who was the laboratory Safety and Training supervisor, her department supervisor, and his assistant were the only people who knew how to do the screen. “I was storing completed worksheets in a folder,” Oliver said, “and soon I had to transfer them to a 3-inch binder because we had so many being ordered. I started saving slides that scored high so that I could show my fellow lab mates what certain characteristics looked like under the microscope.” She also created case studies to train staff using analyzer printouts and slides from the patients. “It was my little side project to take care of while I was working and training new employees in the hematology department.”

The screen was to become much more than a side project very quickly.

In 2017, there was a hantavirus outbreak in one of the nearby communities. A team from the Centers for Disease Control and Prevention (CDC) came out to visit the local hospitals to educate the medical staff on what to look for in their patients with suspected hantavirus. Among those: the TMC staff. The visit would prove both serendipitous and synergistic.

Mary Choi, MD, MPH, medical officer with the CDC Viral Special Pathogens Branch, said, “Members of my branch were asked to come to Navajo Nation [Lukachukai chapter, Arizona] because of a cluster of hantaviruses cases that had been occurring in the area over the course of a few years. During a meeting with medical providers at TMC, our team met Tarrah and she told us that TMC had implemented the screen. We were really intrigued and impressed by the initiative of this small community hospital.”

“We were excited that the CDC even knew we existed!” Oliver recalled. “This little lab in the middle of the reservation.”

HCPS is rare but severe. It can quickly progress from nonspecific initial symptoms, such as fever, body aches, and shortness of breath, to severe respiratory distress. Without immediate intervention, patients usually die within 24 to 48 hours of the onset of cardiopulmonary symptoms. “What makes the disease even more challenging,” said Choi, “is that some of the critical lifesaving measures that physicians normally employ to save a critically-ill patient can actually make the situation worse.

“For example, when HCPS patients reach the cardiopulmonary phase of the illness, their blood pressure will drop. The normal response to this is to give IV fluids (IVF). But in hantavirus, giving IVF can actually make the signs and symptoms of the disease worse and only judicious use of IVF is recommended.”

Testing the test

The screen is based on 5 criteria identified as hallmarks of HCPS: thrombocytopenia, elevated hemoglobin/hematocrit, a left shift on neutrophils, absence of significant toxic granulation of the neutrophils, and immunoblasts and plasma cells more than 10% of lymphoid cells.

According to the study findings, the thrombocytopenia seen in patients with hantavirus tends to be profound, with platelet counts decreasing more than 20 × 103 μL per 12 hours. A decade-long retrospective review, the authors note, confirmed that individuals with hantavirus score high on the 5-point screen, receiving an average score of 4.22 out of 5. The review also found that by using a score cutoff of 4 out of 5, the screen demonstrated a sensitivity of 89% and a specificity of 93% for HCPS.

The study to test the screen’s ability to separate hantavirus patients from those with COVID-19 was conducted at TMC, Emory University Hospital, and Emory University Hospital Midtown. From April to May 2020, TMC used the screen for all patients with signs and symptoms suggestive of COVID-19. In March and April 2020, the Emory sites retrospectively identified all patients with a positive molecular COVID-19 test.

The TMC cohort was 100% American Indian and had a mean age of 53 years. Emory represented a slightly older (mean age, 61 years), largely African American population. TMC patients were more likely to be obese and have preexisting liver disease. The Emory cohort had higher rates of hypertension, lung disease, and kidney disease. At the time of sample collection, 87% of participants at TMC had respiratory symptoms and 46% had an oxygen saturation < 90%. In the Emory cohort, 76% of participants had respiratory symptoms and 12% had an oxygen saturation less than 90%. However, individuals at Emory were more likely to be treated with invasive ventilation, and 1 individual received ECMO.

The 69 patients at TMC had a mean score of 1.48. The mean score from 70 patients at the Emory sites was 2.00. One patient at TMC and two at Emory received a score of 4. None of the 139 participants who were positive for COVID-19 received a score of 5 on the hantavirus 5-point screen.

Pages

Recommended Reading

COVID-19 vaccines provide 5 times the protection of natural immunity, CDC study says
Federal Practitioner
Severe COVID two times higher for cancer patients
Federal Practitioner
COVID vaccines’ protection dropped sharply over 6 months: Study
Federal Practitioner
Early trials underway to test mushrooms as COVID treatment
Federal Practitioner
Unvaccinated people 20 times more likely to die from COVID: Texas study
Federal Practitioner
Alcohol-related liver disease severity increased during COVID-19 pandemic
Federal Practitioner
Whistleblowers will play key role in enforcing workplace vaccine mandate
Federal Practitioner
COVID-19 vaccine mandates are working, public health experts say
Federal Practitioner
What to do about pandemic PTSD
Federal Practitioner
Pandemic stresses harder on physician moms than physician dads: Study
Federal Practitioner